BNP Paribas Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $404K | Sell |
7,619
-124,745
| -94% | -$6.61M | ﹤0.01% | 811 |
|
2025
Q1 | $5.74M | Buy |
132,364
+115,352
| +678% | +$5M | 0.02% | 526 |
|
2024
Q4 | $956K | Buy |
17,012
+10,846
| +176% | +$609K | ﹤0.01% | 778 |
|
2024
Q3 | $420K | Sell |
6,166
-1,492
| -19% | -$102K | ﹤0.01% | 832 |
|
2024
Q2 | $324K | Sell |
7,658
-3,579
| -32% | -$151K | ﹤0.01% | 917 |
|
2024
Q1 | $776K | Sell |
11,237
-12,334
| -52% | -$852K | ﹤0.01% | 770 |
|
2023
Q4 | $1.74M | Buy |
23,571
+11,536
| +96% | +$854K | ﹤0.01% | 687 |
|
2023
Q3 | $821K | Buy |
12,035
+172
| +1% | +$11.7K | ﹤0.01% | 744 |
|
2023
Q2 | $1.11M | Sell |
11,863
-155
| -1% | -$14.6K | ﹤0.01% | 719 |
|
2023
Q1 | $815K | Buy |
12,018
+359
| +3% | +$24.3K | ﹤0.01% | 766 |
|
2022
Q4 | $577K | Buy |
+11,659
| New | +$577K | ﹤0.01% | 826 |
|
2022
Q3 | – | Sell |
-26,814
| Closed | -$1.06M | – | 928 |
|
2022
Q2 | $1.06M | Buy |
26,814
+22,104
| +469% | +$871K | ﹤0.01% | 776 |
|
2022
Q1 | $329K | Buy |
4,710
+860
| +22% | +$60.1K | ﹤0.01% | 817 |
|
2021
Q4 | $300K | Buy |
+3,850
| New | +$300K | ﹤0.01% | 863 |
|
2021
Q3 | – | Sell |
-1,609
| Closed | -$200K | – | 894 |
|
2021
Q2 | $200K | Buy |
+1,609
| New | +$200K | ﹤0.01% | 896 |
|
2020
Q3 | – | Sell |
-2,331
| Closed | -$203K | – | 829 |
|
2020
Q2 | $203K | Buy |
+2,331
| New | +$203K | ﹤0.01% | 793 |
|
2020
Q1 | – | Sell |
-2,331
| Closed | -$216K | – | 800 |
|
2019
Q4 | $216K | Sell |
2,331
-646
| -22% | -$59.9K | ﹤0.01% | 808 |
|
2019
Q3 | $269K | Sell |
2,977
-338
| -10% | -$30.5K | ﹤0.01% | 805 |
|
2019
Q2 | $391K | Buy |
+3,315
| New | +$391K | ﹤0.01% | 805 |
|